http://orcid.org/0000-0002-2976-1861
References
- Childress J, Lokich J. Cutaneous hand and foot toxicity associated with cancer chemotherapy. Am J Clin Oncol. 2003;26:435–436.
- Dow EN, Piccolo J, Segal EM, et al. Drug induced periarticular thenar erythema with onycholysis related to nano-albumin bound paclitaxel therapy. Cancer Treat Commun. 2015;4(Supplement C):161–164.
- Rodríguez-Lomba E, Molina-López I, Suárez-Fernández R, et al. Periarticular thenar erythema and onycholysis syndrome: a manifestation of taxane-induced cutaneous toxicity. Actas Dermo-Sifiliográficas Engl Ed. 2017;108:595–597.
- Scotté F, Tourani JM, Banu E, et al. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol off J Am Soc Clin Oncol. 2005;23:4424–4429.
- Scotté F, Banu E, Medioni J, et al. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer. 2008;112:1625–1631.